Oncology

We are delighted to announce the release of the latest EMJ Oncology issue! Inside, you will find a variety of content, including our…

This engaging symposium at the 2025 ESMO Gynaecological Cancers Congress explored treatment strategies in advanced endometrial…

Sponsored Content: This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…

Overcoming Resistance: How Targeted Approaches Are Changing Management of Advanced EGFR-Mutant Lung Cancer and Pavingthe Way for Precision…

A review of the latest strategies for managing oestrogen therapy resistance in ER+/HER2− metastatic breast cancer, focusing on biomarker…

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been associated…

In our latest issue of EMJ Oncology you can find exclusive interviews with experts in the field, insightful peer-reviewed articles, and an…

The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…